FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,618 | -59.5% | 18,216 | -9.0% | 0.02% | -58.9% |
| Q2 2023 | $95,319 | +153.9% | 20,025 | +204.1% | 0.06% | +166.7% |
| Q1 2023 | $37,535 | -59.2% | 6,585 | -27.7% | 0.02% | -56.2% |
| Q4 2022 | $91,950 | -27.0% | 9,113 | +62.5% | 0.05% | -4.0% |
| Q3 2022 | $126,000 | -8.7% | 5,607 | +0.7% | 0.05% | -2.0% |
| Q2 2022 | $138,000 | +15.0% | 5,566 | +80.1% | 0.05% | -5.6% |
| Q1 2022 | $120,000 | -37.5% | 3,091 | -5.6% | 0.05% | -26.0% |
| Q4 2021 | $192,000 | +37.1% | 3,274 | +39.0% | 0.07% | +17.7% |
| Q3 2021 | $140,000 | -35.2% | 2,356 | -5.2% | 0.06% | -30.3% |
| Q2 2021 | $216,000 | -15.6% | 2,486 | -20.1% | 0.09% | -17.6% |
| Q1 2021 | $256,000 | -7.9% | 3,110 | +1.6% | 0.11% | -6.1% |
| Q4 2020 | $278,000 | -30.7% | 3,061 | -69.5% | 0.12% | -45.2% |
| Q3 2020 | $401,000 | +2.6% | 10,028 | -12.0% | 0.21% | +13.5% |
| Q2 2020 | $391,000 | -8.0% | 11,389 | -40.5% | 0.18% | +5.7% |
| Q1 2020 | $425,000 | -0.9% | 19,135 | -12.7% | 0.18% | +150.0% |
| Q4 2019 | $429,000 | +95.0% | 21,917 | +54.6% | 0.07% | +59.1% |
| Q3 2019 | $220,000 | -27.6% | 14,176 | -5.3% | 0.04% | -31.2% |
| Q2 2019 | $304,000 | +4.1% | 14,965 | -9.9% | 0.06% | -89.7% |
| Q1 2019 | $292,000 | +24.3% | 16,612 | -9.4% | 0.62% | +1452.5% |
| Q4 2018 | $235,000 | -62.2% | 18,340 | -51.9% | 0.04% | -37.5% |
| Q3 2018 | $621,000 | -17.1% | 38,094 | -42.3% | 0.06% | -90.3% |
| Q2 2018 | $749,000 | – | 66,073 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $51,820,000 | 67.63% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $307,258,000 | 39.62% |
| Darwin Global Management, Ltd. | 952,847 | $86,642,000 | 24.18% |
| Redmile Group, LLC | 12,629,737 | $1,148,422,000 | 13.91% |
| DAFNA Capital Management LLC | 334,360 | $30,403,000 | 9.05% |
| Casdin Capital, LLC | 3,050,000 | $277,337,000 | 8.22% |
| Grosvenor Holdings, L.L.C. | 1,459,517 | $132,714,000 | 7.23% |
| Copernicus Capital Management, LLC | 3,240 | $295,000 | 4.60% |
| Eversept Partners, LP | 399,499 | $36,326,444 | 4.26% |
| Ally Bridge Group (NY) LLC | 260,000 | $23,642,000 | 4.05% |